Why Once Daily Oral Medication is Replacing Twice-Daily Insulin in Feline Diabetes Care
20 20 people viewed this event.
Join Dr. Susan Little on September 29, 2026, at 7 p.m. (EDT) for this presentation on the newest SGLT2 inhibitor option for diabetic cats in Canada.
A new era in feline medicine began in 2024 when the first SGLT2 inhibitor for diabetic cats in Canada was introduced (velagliflozin). Now a second SGLT2 inhibitor (bexagliflozin) is finally available. This webinar will build on the experiences of using this drug class in cats to highlight what we have learned and to introduce bexagliflozin, a new option that will improve quality of life for diabetic cats and their owners.
Click here to register: Webinar Registration – Zoom
Additional Details
What is the format of the online event? - Live (Interactive)
Ticket Options - Free
CE Credits - 1